Citigroup’s ARK Genomic Revolution ETF ARKG Stock Holding History

Citigroup’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-105,000	Closed	-$2.92M	–	6053
2025 Q3	$2.92M	Hold	105,000	–	–	﹤0.01%	2368
2025 Q2	$2.56M	Hold	105,000	–	–	﹤0.01%	2429
2025 Q1	$2.18M	Hold	105,000	–	–	﹤0.01%	2620
2024 Q4	$2.47M	Hold	105,000	–	–	﹤0.01%	2634
2024 Q3	$2.69M	Hold	105,000	–	–	﹤0.01%	2404
2024 Q2	$2.47M	Buy	+105,000	New	+$2.65M	﹤0.01%	2173
2022 Q3	–	Sell	-29,700	Closed	-$935K	–	5809
2022 Q2	$935K	Buy	+29,700	New	+$1.04M	﹤0.01%	2715
2021 Q4	–	Sell	-242,500	Closed	-$18.1M	–	5807
2021 Q3	$18.1M	Buy	+242,500	New	+$20.3M	0.01%	1063

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup's ARKG Position: Q2 2026 in Review

Citigroup increased its ARK Genomic Revolution ETF (ARKG) stake by 14% in Q2 2026, buying an estimated $8.7M and bringing the position to 2,172,315 shares worth $91.4M. The position accounts for 0.03% of the portfolio, ranked #511.

Citigroup first reported a position in ARKG in Q1 2018 and has held it in 34 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Citigroup held 2,172,315 shares of ARK Genomic Revolution ETF worth $91.4M as of Q2 2026.
Citigroup bought 273,271 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $8.7M.
ARK Genomic Revolution ETF made up 0.03% of Citigroup's portfolio in Q2 2026, its #511 holding.
Citigroup first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 34 quarters since.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.